CureME is a research group based at the London School of Hygiene & Tropical Medicine.
London
Be the first to know and let us send you an email when UK ME CFS Biobank posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to UK ME CFS Biobank:
CureME is a research group based at the London School of Hygiene & Tropical Medicine, with expertise in clinical epidemiology and laboratory science, which runs several major studies into ME/CFS. Our research has focused on improving recognition, diagnosis and treatment of ME/CFS, leading to the opening of the UK’s first ME/CFS Biobank (UKMEB) – now open to external researchers across the globe.
ME/CFS is a severe, debilitating disease presenting with multi-systemic symptoms, usually including but not restricted to severe fatigue. CFS / “chronic fatigue syndrome” is used in some contexts to represent a wide range of conditions resulting in chronic fatigue, including but not limited to ME/CFS. Up to 250,000 people suffer from ME/CFS in the UK alone, but although the consequences can be very severe, the cause is still unknown.
One of our main projects to aid understanding of ME/CFS is the UK ME/CFS Biobank. The UKMEB Biobank (UKMEB) is the first ME-specific biobank in Europe, and one of the first in the world. Hosted at the Royal Free Hospital in London, it has collected over 30,000 aliquots of blood from patients with ME/CFS and multiple sclerosis (as well as healthy controls), using a rigorous and consistent set of scientific protocols.
The UKMEB’s mission is to sustain an open biobank that drives high-quality, ethical investigations into the clinical and biomedical understanding of ME/CFS. In doing so, it fosters cooperation and collaboration between researchers and enhances the opportunity for breakthrough discoveries.
